Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosusSerena Fasano, Valentina Messiniti, Michele Iudici, Melania Alessia Coscia, Francesco Ciccia
11 January 2023
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeksBinod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew
5 May 2023
Molecular endotypes of type 1 and type 2 SLERobert Robl, Amanda Eudy, Prathyusha S Bachali, Jennifer L Rogers, Megan Clowse, David Pisetsky, Peter Lipsky
30 January 2023
Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectivesEya Toumi, Soraya Mezouar, Anne Plauzolles, Laurent Chiche, Nathalie Bardin, Philippe Halfon, Jean Louis Mege
22 February 2023
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosusSebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H Giordano, Maria E Suarez-Almazor
14 February 2023
Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technologyBessie Stamm, Medha Barbhaiya, Caroline Siegel, Sarah Lieber, Michael Lockshin, Lisa Sammaritano
13 December 2022
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritisAhmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris III, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gábor G Illei, S Sam Lim, Wendy I White
30 January 2023
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trialsIan N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
13 January 2023
Lupus spectrum ambiguity has long-term negative implications for patientsIan N Bruce, Joy Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Roger A Levy, Victoria P Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi
11 January 2023
Clinical associations of cognitive dysfunction in systemic lupus erythematosusSudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, Rangi Kandane-Rathnayake, Eric F Morand, Julie C Stout, Alberta Hoi
28 February 2023
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspectiveJoy Buie, Lauren Bloch, Eric F Morand, Ronald F van Vollenhoven, Victoria P Werth, Zahi Touma, Peter Lipsky, Kenneth Kalunian, Anca D Askanase, L Ines, Christopher Reed, MaryBeth Son, Timothy Franson, Karen Costenbader, Laura Eve Schanberg
14 February 2023
1202 Voclosporin for Lupus Nephritis: Results of the Two-year AURORA 2 Continuation StudyAmit Saxena, Onno Teng, Chris Collins, Nicole England, Henry Leher
14 December 2022
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquineCelline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle A Petri, Ellen M Ginzler, Daniel J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary-Anne Dooley, Christine Peschken, David IsenbergSee the full list of authors
17 November 2022
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial dataDavid D'Cruz, Gina Eriksson, Yulia Green, Anne Hammer, Beulah Ji, Paige Meizlik, David A Roth
24 March 2023
Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr miceXin Zhang, Juan Meng, Xuhua Shi, Robert James Quinet, William Davis, Jerald Zakem, Chandana Keshavamurthy, Ronak Patel, Gitanjali Lobo, Linh Hellmers, Alicia Nicole Ray, Laura E Rivers, Hiba Ali, Therese Posas-Mendoza, Chad HilleSee the full list of authors
11 April 2023
Remission of lupus nephritis: the trajectory of histological response in successfully treated patientsAna Malvar, Valeria Alberton, Bruno Lococo, Maria Lourenco, Joaquin Martinez, Lucrecia Burna, Celeste Besso, Jordi Navarro, Haikady N Nagaraja, Aastha Khatiwada, Bethany Wolf, Brad Rovin
31 May 2023
Gender differences in SLE: report from a cohort of 417 Caucasian patientsFrancesca Trentin, Viola Signorini, Maria Laura Manca, Giancarlo Cascarano, Luca Gualtieri, Davide Schilirò, Anastasiya Valevich, Chiara Cardelli, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Stagnaro, Dina Zucchi, Chiara Tani, Marta Mosca
25 April 2023
Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral densitySergii Shevchuk, Liubov Marynych, Tetiana Malovana, Liudmyla Denyshchych
9 August 2023
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve studyJacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, Anna Richards, Yun Irene Gregan, Holly Quasny, Deven Chauhan
30 November 2022
Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from ChinaHui Jin, Shihang Zhou, Yangyiyi Yu, Ming Zhao, Haijing Wu, Hai Long, Siqi Fu, Ruifang Wu, Heng Yin, Jieyue Liao, Shuangyan Luo, Yu Liu, Qing Zhang, Peng Zhang, Yixin TanSee the full list of authors
20 March 2023